RG
IBB icon

Rikoon Group’s iShares Biotechnology ETF IBB Stock Holding History

Rikoon Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$232K Buy
+1,542
New +$245K 0.06% 214

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Rikoon Group's IBB Position: Q1 2021 in Review

Rikoon Group opened a new position in iShares Biotechnology ETF (IBB) in Q1 2021: 1,542 shares worth $232K. The stake represents 0.06% of the portfolio and ranks #214 among its holdings.

845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

  • Rikoon Group held 1,542 shares of iShares Biotechnology ETF worth $232K as of Q1 2021.
  • iShares Biotechnology ETF was a new Rikoon Group position in Q1 2021.
  • iShares Biotechnology ETF made up 0.06% of Rikoon Group's portfolio in Q1 2021, its #214 holding.
  • 845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.